COVID-19 Susceptibility in chronic obstructive pulmonary disease

Area of Science:

• Pulmonary Medicine
• Infectious Diseases
• Epidemiology

Background:

• COVID-19 has caused millions of deaths globally, with increased risk for the elderly and those with comorbidities.
• Chronic obstructive pulmonary disease (COPD) patients have impaired pulmonary defenses and immune dysfunction, suggesting higher susceptibility to respiratory infections.
• Conflicting data exists on COPD's impact on COVID-19 prognosis, potentially leading to reduced precautions.

Purpose of the Study:

• To review current research on the implications of coronavirus infection in patients with COPD.
• To clarify the relationship between COPD and susceptibility to SARS-CoV-2.
• To assess the impact of COPD on COVID-19 severity.

Main Methods:

• Systematic review of available epidemiological and clinical research.
• Analysis of studies investigating SARS-CoV-2 infection in COPD populations.
• Discussion of underlying pathophysiological mechanisms linking COPD and viral respiratory infections.

Main Results:

• COPD patients exhibit impaired pulmonary defenses and immune dysfunction, increasing susceptibility to viral infections.
• Available data suggests COPD may increase susceptibility to SARS-CoV-2 and worsen COVID-19 severity, though large-scale validation is pending.
• Smoking history and exposure to harmful particles in COPD patients contribute to long-term pulmonary defense impairment.

Conclusions:

• COPD is likely associated with increased susceptibility to SARS-CoV-2 and more severe COVID-19 outcomes.
• Specific monitoring and assessment strategies for COPD patients during the pandemic are crucial.
• Further large-scale studies are needed to validate these findings and inform clinical practice.